Prognosis looks good for healthcare M&A in 2019
This year, one of the real focus areas for M&A activity will be specialty services, including dermatology, ophthalmology, fertility, orthopedics, and gastroenterology. ASCs and multispecialty medical groups are also on the radar screen. Niche areas within healthcare are still highly fragmented and underpenetrated. Today, many operators own fewer than five locations and lack a dominant market position. This dynamic presents numerous opportunities for consolidation as well as organic growth.
Rising valuations in the healthcare space are now catching the attention of small practices. Many founding physicians in these specialty areas have built their practices to a reasonable size and are reaching a point in their careers where they want to exit. They are quickly realizing they can sell for a premium in the current market and, thus, may be receptive to potential acquirers.
Just recently, for instance, Orthopedic Associates, which has 12 providers and multiple locations across the greater Oklahoma City area, joined Mercy Clinic. In a second example, CEI Vision Partners, a portfolio company of private equity firm Revelstoke Capital Partners LLC, acquired Virginia Eye Consultants, an ophthalmology group comprised of 17 providers that service the Norfolk, Virginia Beach, and Chesapeake markets.
These are just a few of the many midmarket deals we can expect to see this year in specialty healthcare services. Given the availability of capital and the financially attractive characteristics of this market, expect to see a further increase in acquisition activity by both strategic and financial buyers.
Due diligence plays an important role to ensure investors get what they bargain for. Here are a few important variables to take into consideration:
Our experience with most practices is that internal financial statements are prepared on a cash basis of accounting. Therefore, it is critical to understand the cash to accrual adjustments; specifically, on the revenue side. In a growing practice, this can significantly impact earnings.
Sellers, for their part, need to conduct their own internal diligence to make themselves more attractive to buyers. It’s not uncommon for specialty practices to lack sophistication in terms of accounting and financial reporting. In general, these groups should convert to generally accepted accounting principles (GAAP) which will give their numbers more credibility among potential investors—and can ultimately lead to higher valuations.
The prognosis for M&A activity in specialty practices looks promising this year. But both buyers and sellers should properly prepare so they can be equally well-positioned to seize opportunities that can generate healthy returns.
Related Services
-
Press ReleaseHigginbotham joins CohnReznick as Principal, Healthcare Advisory LeaderCohnReznick LLP, one of the leading advisory, assurance, and tax firms in the United States, today announced that Shayla Higginbotham, MHA, PMP has joined the firm as Principal and Healthcare Advisory Leader.
-
InsightPhysician practices: M&A trends and outlookAlthough there is uncertainty in the physician practices sector, we believe the sector is well-positioned to attract investor activity in 2023 and beyond. Learn more.
-
InsightHow healthcare services consolidation and MSOs benefit buyers and sellersBuy and build strategies designed to consolidate fragmented subsectors is driving deal volume in the healthcare space. Learn how healthcare services consolidation and MSOs can benefit buyers and sellers.
-
InsightNew York State HWB Program: The first employer submission period for bonuses has openedAparna Mekala, Joanne McNamaraThe HWB Program has launched in New York state. Here are three considerations for healthcare providers. Read more.
-
Press ReleaseCohnReznick earns three M&A Atlas awards for transactions workCohnReznick's award-winning Transaction Advisory Services team was recognized by Global M&A Network as the Transactions Advisor of the Year and earned awards for U.S.A. Private Equity Deal of the Year – Middle Markets and Health Care Deal of the Year during the 13th Annual Americas M&A Atlas Awards celebrations.